Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is soliciting grant applications for exploratory research projects focused on the development and validation of emerging technologies for molecular and cellular analysis in cancer research. The goal of this funding opportunity is to support projects that can accelerate and enhance research in areas such as cancer biology, early detection, clinical diagnosis, treatment, and epidemiology. Applicants should propose innovative technologies that can improve molecular and cellular characterizations of cancer. Some key areas of focus include: • Cancer biology and early detection • Clinical diagnosis and treatment • Epidemiology and cancer health disparities • Development and validation of emerging technologies for molecular and cellular analysis This funding opportunity is part of the NCI's Innovative Molecular Analysis Technologies (IMAT) Program.